Home > Financial Ratios > OXYGENTA PHARMACEUTICAL

OXYGENTA PHARMACEUTICAL
Core EBITDA Margin

    Back to All Ratios
OXYGENTA PHARMACEUTICAL is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for OXYGENTA PHARMACEUTICAL
Please provide your vote to see the results

OXYGENTA PHARMACEUTICAL Last 5 Year Core EBITDA Margin History

[Standalone]

Mar2026Mar2025Mar2024Mar2023Mar2022
   Core EBITDA Margin(%) -13.55-8.98-24.46-22.972.44

What is the latest Core EBITDA Margin ratio of OXYGENTA PHARMACEUTICAL ?

The latest Core EBITDA Margin ratio of OXYGENTA PHARMACEUTICAL is -13.55 based on Mar2026 Standalone results.
Year Core EBITDA Margin
Mar2026-13.55
Mar2025-8.98
Mar2024-24.46
Mar2023-22.97
Mar20222.44

How is Core EBITDA Margin of OXYGENTA PHARMACEUTICAL Trending?

Years Core EBITDA Margin % Change
Mar2026 -13.55
Negative
Mar2025 -8.98
Negative
Mar2024 -24.46
Negative
Mar2023 -22.97
Negative
Mar2022 2.44 -

Other Financial Ratios of OXYGENTA PHARMACEUTICAL


Compare Core EBITDA Margin ratio of peers of OXYGENTA PHARMACEUTICAL

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
OXYGENTA PHARMACEUTICAL ₹186.4 Cr -1.2% 5% -52.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹467,870.0 Cr -1.4% 2.4% 17.1% Stock Analytics
DIVIS LABORATORIES ₹220,946.0 Cr 12.2% 23.1% 21.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹190,907.0 Cr 2.4% 5.3% 41.7% Stock Analytics
CIPLA ₹118,674.0 Cr 1.7% 0.7% -3.8% Stock Analytics
DR REDDYS LABORATORIES ₹97,648.7 Cr 3% -14.9% -10.2% Stock Analytics


OXYGENTA PHARMACEUTICAL Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
OXYGENTA PHARMACEUTICAL

-1.2%

5%

-52.3%

SENSEX

2.4%

1.5%

-4.3%


You may also like the below Video Courses